Comments
Loading...
Algorae Pharmaceuticals Analyst Ratings and Price Targets | OTC:LVCLF | Benzinga
Algorae Pharmaceuticals Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Algorae Pharmaceuticals Corp from these most-recent analyst ratings.
Analyst Ratings for Algorae Pharmaceuticals
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Algorae Pharmaceuticals (LVCLF) stock?
There is no price target for Algorae Pharmaceuticals
What is the most recent analyst rating for Algorae Pharmaceuticals (LVCLF)?
There is no analyst for Algorae Pharmaceuticals
When was the last upgrade for Algorae Pharmaceuticals (LVCLF)?
There is no last upgrade for Algorae Pharmaceuticals
When was the last downgrade for Algorae Pharmaceuticals (LVCLF)?
There is no last downgrade for Algorae Pharmaceuticals.
When is the next analyst rating going to be posted or updated for Algorae Pharmaceuticals (LVCLF)?
There is no next analyst rating for Algorae Pharmaceuticals.
Is the Analyst Rating Algorae Pharmaceuticals (LVCLF) correct?
There is no next analyst rating for Algorae Pharmaceuticals.
Browse analyst ratings and price targets on all stocks.